Sfoglia per AUTORE
PASSARO A
Collezione AOU San Luigi di Orbassano
Items : 10
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21.
2024
AOU San Luigi di Orbassano
Bertolaccini L; Tralongo AC; Del Re M; Facchinetti F; Ferrara R; Franchina T; Graziano P; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Cinquini M; Passiglia F; Novello S;
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Feb;194:104243. doi: 10.1016/j.critrevonc.2023.104243. Epub 2023 Dec 20
2024
AOU San Luigi di Orbassano
Russano M; Petrini I; Metro G; Catino A; Bonanno L; Bennati C; Bironzo P; Russo GL; Passaro A;
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18
2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano
Rocco D; Migliorino MR; Parra HS; Pagni F; Seminati D; Passaro A; Tiseo M; Cortinovis D; Galetta D; Belluomini L; Pepe F; Pisapia P; Passiglia F; Reale ML; Malapelle U; Pilotto S; Troncone G; Novello S;
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. in Cancers / Cancers (Basel). 2021 Jun 11;13(12):2935. doi: 10.3390/cancers13122935.
2021
AOU San Luigi di Orbassano
Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Feb;152:127-134. doi: 10.1016/j.lungcan.2020.12.011. Epub 2020 Dec 17.
2021
AOU San Luigi di Orbassano
Novello S; Mukhametshina GZ; Schumacher M; Rizzato S; Ostoros G; Tsoi D; Gottfried M; Metro G; Migliorino MR; Passaro A; Hochmair M; Egorova I; Poltoratskiy A; Laktionov KK; de Marinis F; Dziadziuszko R; Tang W; Clementi L; Cseh A; Kowalski D;
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Aug 10;39(23):2574-2585. doi: 10.1200/JCO.20.02574. Epub 2021 Jun 2.
2021
AOU San Luigi di Orbassano
Passiglia F; Cinquini M; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Larici AR; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28
2020
AOU San Luigi di Orbassano
Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings. in La Radiologia medica / Radiol Med. 2020 Feb;125(2):214-219. doi: 10.1007/s11547-019-01094-w. Epub 2019 Oct 11.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Ferrari K; Piperno G; Tindara F; Chiari R; Bearz A; Passaro A; Trovò M; Bezzi M; Vattemi E; Comin C; Andolina M; Badellino S; Buffoni L; Ramella S; Giaj-Levra N; Borghetti P; Bruni A; Franceschini D; Filippi AR; Genovesi D; Scotti V;
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25
2020
AOU San Luigi di Orbassano
Rossi G; Ramella S; Pilotto S; Passaro A; Menis J; Franchina T; Malapelle U; Ferrara R; Facchinetti F; Del Re M; Passiglia F; Bertolaccini L; Trisolini R; Novello S;
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.
2018
AOU San Luigi di Orbassano
Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; Cecere FL; Giannarelli D; Luciani A; Bearz A; Tuzi A; Scotti V; Tonini G; Galetta D; Carta A; Soto Parra H; Rebonato A; Morabito A; Chiari R;